Azurity Pharmaceuticals Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
800
- Latest Deal Type
-
Debt
- Financing Rounds
-
7
- Investments
-
5
Azurity Pharmaceuticals General Information
Description
Operator of a pharmaceutical company that develops and markets medicines for patients with unmet medical needs. The company's products include medications for a variety of conditions, including attention deficit hyperactivity disorder (ADHD), hypertension and congestive heart failure as well as focuses on developing and commercializing oral liquid medications, thereby helping children, elderly patients and others who have difficulty swallowing pills or tablets.
Contact Information
Website
www.azurity.comCorporate Office
- 8 Cabot Road
- Suite 2000
- Woburn, MA 01801
- United States
Corporate Office
- 8 Cabot Road
- Suite 2000
- Woburn, MA 01801
- United States
Azurity Pharmaceuticals Timeline
Azurity Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Azurity Pharmaceuticals Comparisons
Industry
Financing
Details
Azurity Pharmaceuticals Competitors (2)
One of Azurity Pharmaceuticals’s 2 competitors is Ethypharm, a Private Equity-Backed company based in Saint Cloud, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ethypharm | Private Equity-Backed | Saint Cloud, France | ||||
| Prometheus Laboratories | Formerly VC-backed | San Diego, CA |
Azurity Pharmaceuticals Patents
Azurity Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240285582-A1 | Stable pharmaceutical compositions of edaravone | Pending | 16-Feb-2023 | ||
| US-20240156829-A1 | Stable antiemetic emulsions for parenteral administration | Pending | 31-Oct-2022 | ||
| US-20240197705-A1 | Stable pharmaceutical compositions of apixaban | Active | 27-Jul-2022 | ||
| US-12213972-B2 | Stable pharmaceutical compositions of apixaban | Active | 27-Jul-2022 | ||
| US-20230381282-A1 | Stable liquid compositions of glucagon | Active | 26-May-2022 | A61K38/26 |
Azurity Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Azurity Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Azurity Pharmaceuticals Investments (5)
Azurity Pharmaceuticals’s most recent deal was a Buyout/LBO with Covis Pharma. The deal was made on 14-Mar-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Covis Pharma | 14-Mar-2025 | Buyout/LBO | Pharmaceuticals | ||
| Slayback Pharma | 27-Sep-2023 | Buyout/LBO | Drug Discovery | ||
| Arbor Pharmaceuticals | 20-Sep-2021 | Buyout/LBO | Pharmaceuticals | ||
| Eton Pharmaceuticals (Neurology Portfolio) | 08-Feb-2021 | Buyout/LBO | Buildings and Property | ||
| Silvergate Pharmaceuticals | 01-May-2019 | Buyout/LBO | Pharmaceuticals |
Azurity Pharmaceuticals Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Covis Pharma | Luxembourg, Luxembourg | 2011 | |
| Arbor Pharmaceuticals | Atlanta, GA |
Azurity Pharmaceuticals FAQs
-
When was Azurity Pharmaceuticals founded?
Azurity Pharmaceuticals was founded in 1998.
-
Where is Azurity Pharmaceuticals headquartered?
Azurity Pharmaceuticals is headquartered in Woburn, MA.
-
What is the size of Azurity Pharmaceuticals?
Azurity Pharmaceuticals has 800 total employees.
-
What industry is Azurity Pharmaceuticals in?
Azurity Pharmaceuticals’s primary industry is Drug Delivery.
-
Is Azurity Pharmaceuticals a private or public company?
Azurity Pharmaceuticals is a Private company.
-
What is Azurity Pharmaceuticals’s current revenue?
The current revenue for Azurity Pharmaceuticals is .
-
How much funding has Azurity Pharmaceuticals raised over time?
Azurity Pharmaceuticals has raised $36.1M.
-
Who are Azurity Pharmaceuticals’s investors?
NovaQuest Capital Management has invested in Azurity Pharmaceuticals.
-
Who are Azurity Pharmaceuticals’s competitors?
Ethypharm and Prometheus Laboratories are competitors of Azurity Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
